Modifiable prognostic factors in uterine fibroid development: a systematic review of literature

References

• Al-Hendy, A., et al., 2015. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells. The Journal of Clinical Endocrinology and Metabolism, 100 (4), E572–E582.
   PubMed Web of Science ®Google Scholar
• Al-Hendy, A., Myers, E.R. and Stewart, E., 2017. Uterine Fibroids: Burden and unmet medical need. Seminars in Reproductive Medicine, 35 (6), 473–480.
   PubMed Web of Science ®Google Scholar
• Armbrust, R., et al., 2018. The growth of uterine myomas in untreated women: influence factors and ultrasound monitoring. Archives of Gynecology and Obstetrics, 297 (1), 131–137.
   PubMed Web of Science ®Google Scholar
• Baird, D.D., et al., 2007. Association of physical activity with development of uterine leiomyoma. American Journal of Epidemiology, 165 (2), 157–163.
   PubMed Web of Science ®Google Scholar
• Baird, D.D., et al., 2011. Short-term change in growth of uterine leiomyoma: tumor growth spurts. Fertility and Sterility, 95 (1), 242–246.
   PubMed Web of Science ®Google Scholar
• Baird, D.D., et al., 2013. Vitamin d and the risk of uterine fibroids. Epidemiology, 24 (3), 447–453.
   PubMed Web of Science ®Google Scholar
• Baird, D.D., et al., 2020. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans. Am.J.Obstet.Gynecol, 223 (3), 402.
   Web of Science ®Google Scholar
• Bidgoli, S.A., et al., 2012. Role of endocrine disrupting chemicals in the occurrence of benign uterine leiomyomata: special emphasis on AhR tissue levels. Asian Pacific Journal of Cancer Prevention, 13 (11), 5445–5450.
   PubMedGoogle Scholar
• Blauer, M., et al., 2009. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertility and Sterility, 91 (5), 1919–1925.
   PubMed Web of Science ®Google Scholar
• Borahay, M.A., et al., 2016. Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study. Am.J.Obstet.Gynecol, 215 (6), 750.
   Web of Science ®Google Scholar
• Bray, M.J., et al., 2018. Evaluating risk factors for differences in fibroid size and number using a large electronic health record population. Maturitas, 114, 9–13.
   PubMed Web of Science ®Google Scholar
• Chiaffarino, F., et al., 1999a. Diet and uterine myomas. Obstetrics and Gynecology, 94 (3), 395–398.
   PubMed Web of Science ®Google Scholar
• Chiaffarino, F., et al., 1999b. Use of oral contraceptives and uterine fibroids: results from a case-control study. British Journal of Obstetrics and Gynaecology, 106 (8), 857–860.
   PubMedGoogle Scholar
• Ciebiera, M., et al., 2016. Influence of vitamin D and transforming growth factor Î23 serum concentrations, obesity, and family history on the risk for uterine fibroids. Fertility and Sterility, 106 (7), 1787–1792.
   PubMed Web of Science ®Google Scholar
• Clark, M.K., et al., 2001. Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception. Fertility and Sterility, 75 (5), 871–877.
   PubMed Web of Science ®Google Scholar
• Corachán, A., et al., 2021. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation. Fertility and Sterility, 115 (2), 512–521.
   PubMed Web of Science ®Google Scholar
• Curtis, K.M. and Martins, S.L., 2006. Progestogen-only contraception and bone mineral density: a systematic review. Contraception, 73 (5), 470–487.
   PubMed Web of Science ®Google Scholar
• Dandolu, V., et al., 2010. BMI and uterine size: is there any relationship? International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists, 29 (6), 568–571.
   PubMed Web of Science ®Google Scholar
• Fischer, N.M., et al., 2021. Angiotensin-converting enzyme inhibitors reduce uterine fibroid incidence in hypertensive women. The Journal of Clinical Endocrinology and Metabolism, 106 (2), e650–e659.
   PubMed Web of Science ®Google Scholar
• Gao, M. & Wang, H. 2018. Frequent milk and soybean consumption are high risks for uterine leiomyoma: A prospective cohort study. Medicine, 97, (41) e12009.
   Google Scholar
• Harmon, Q.E. and Baird, D.D., 2015. Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women. Human Reproduction, 30 (6), 1499–1504.
   PubMed Web of Science ®Google Scholar
• Harmon, Q.E., et al., 2022. Depot medroxyprogesterone acetate use and the development and progression of uterine leiomyoma. Obstetrics and Gynecology, 139 (5), 797–807.
   PubMed Web of Science ®Google Scholar
• Howick, J., et al., 2011. “Explanation of the 2011 Oxford centre for evidence-based medicine (OCEBM) levels of evidence (Background Document)”. Oxford Centre for Evidence-Based Medicine. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/explanation-of-the-2011-ocebm-levels-of-evidence/.
   Google Scholar
• Kumari, R., et al., 2022. Association between serum vitamin D level and uterine fibroid in premenopausal women in Indian population. Drug Discoveries & Therapeutics, 16 (1), 8–13.
   PubMed Web of Science ®Google Scholar
• Lee, J.E., et al., 2018. Weight change and risk of uterine leiomyomas: Korea Nurses’ Health Study. Current Medical Research and Opinion, 34 (11), 1913–1919.
   PubMed Web of Science ®Google Scholar
• Lucero, J., et al., 2001. Early follicular phase hormone levels in relation to patterns of alcohol, tobacco, and coffee use. Fertility and Sterility, 76 (4), 723–729.
   PubMed Web of Science ®Google Scholar
• Magalhaes, J., Aldrighi, J.M. and de Lima, G.R., 2007. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception, 75 (3), 193–198.
   PubMed Web of Science ®Google Scholar
• Martin, C.L., et al., 2011. Serum micronutrient concentrations and risk of uterine fibroids. Journal of Women’s Health (2002), 20 (6), 915–922.
   PubMed Web of Science ®Google Scholar
• Mohammadi, R., et al., 2020. Correlation of low serum vitamin-D with uterine leiomyoma: a systematic review and meta-analysis. Reproductive Biology and Endocrinology, 18 (1), 85.
   PubMed Web of Science ®Google Scholar
• Nagata, C., et al., 2009. Association of intakes of fat, dietary fibre, soya isoflavones and alcohol with uterine fibroids in Japanese women. The British Journal of Nutrition, 101 (10), 1427–1431.
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis, L.L., et al., 2018. Fibroid vascularisation assessed with three-dimensional power Doppler ultrasound is a predictor for uterine fibroid growth: a prospective cohort study. BJOG: An International Journal of Obstetrics and Gynaecology, 125 (5), 577–584.
   PubMed Web of Science ®Google Scholar
• Oskovi Kaplan, Z.A., et al., 2018. 25-Hydroxy vitamin D levels in premenopausal Turkish women with uterine leiomyoma. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 34 (3), 261–264.
   PubMed Web of Science ®Google Scholar
• Page, M.J., et al., 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.), 372, n71.
   PubMed Web of Science ®Google Scholar
• Pan, H., Qin, F., Deng, F., 2021. Clinical value of body mass index and waist-hip ratio in clinicopathological characteristics and prognosis of uterine Leiomyomata. Evidence-based Complementary and Alternative Medicine, 2021, available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2014274176&from=export
   Google Scholar
• Parazzini, F., et al., 2004. Uterine fibroids risk and history of selected medical conditions linked with female hormones. European Journal of Epidemiology, 19 (3), 249–253.
   PubMed Web of Science ®Google Scholar
• Parazzini, F., et al., 1996. Uterine myomas and smoking. Results from an Italian study. The Journal of Reproductive Medicine, 41 (5), 316–320.
   PubMed Web of Science ®Google Scholar
• Payson, M., Leppert, P. and Segars, J., 2006. Epidemiology of myomas. Obstetrics and Gynecology Clinics of North America, 33 (1), 1–11.
   PubMed Web of Science ®Google Scholar
• Peddada, S.D., et al., 2008. Growth of uterine leiomyomata among premenopausal black and white women. Proceedings of the National Academy of Sciences of the United States of America, 105 (50), 19887–19892.
   PubMed Web of Science ®Google Scholar
• Reichman, M.E., et al., 1993. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. Journal of the National Cancer Institute, 85 (9), 722–727.
   PubMedGoogle Scholar
• Sharami, S.H., et al., 2019. Relationship of uterine fibroids with lipid profile, anthropometric characteristics, subcutaneous and preperitoneal fat thickness. Archives of Iranian Medicine , 22 (12), 716–721.
   PubMed Web of Science ®Google Scholar
• Sharan, C., et al., 2011. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertility and Sterility, 95 (1), 247–253.
   PubMed Web of Science ®Google Scholar
• Shawki, O., et al., 2009. Treatment of heavy menstrual bleeding associated with uterine leiomyoma with the levonorgestrel-releasing intrauterine system. Gynecological Surgery, 6 (4), 331–337. available from: https://www.embase.com/search/results?subaction=viewrecord&id=L50493359&from=export
   Google Scholar
• Shen, Y., et al., 2013. Environmental exposure and risk of uterine leiomyoma: An epidemiologic survey. European Review for Medical and Pharmacological Sciences, 17 (23), 3249–3256.
   PubMed Web of Science ®Google Scholar
• Socolov, D., et al., 2011. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma. The European Journal of Contraception & Reproductive Health Care: The Official Journal of the European Society of Contraception, 16 (6), 480–487.
   PubMed Web of Science ®Google Scholar
• Stewart, E.A., et al., 2017. Epidemiology of uterine fibroids: a systematic review. Bjog: An International Journal of Obstetrics and Gynaecology, 124 (10), 1501–1512.
   PubMed Web of Science ®Google Scholar
• Stewart, E.A., et al., 2016. Uterine fibroids. Nature Reviews. Disease Primers, 2 (1), 16043.
   PubMedGoogle Scholar
• Tasci, Y., et al., 2009. Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus. Archives of Gynecology and Obstetrics, 280 (1), 39–42.
   PubMed Web of Science ®Google Scholar
• Terry, K.L., et al., 2007. Anthropometric characteristics and risk of uterine leiomyoma. Epidemiology, 18 (6), 758–763.
   PubMed Web of Science ®Google Scholar
• Velez Edwards, D.R., Baird, D.D. and Hartmann, K.E., 2013. Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment. American Journal of Epidemiology, 178 (3), 426–433.
   PubMed Web of Science ®Google Scholar
• Wise, L.A., et al., 2004a. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. American Journal of Epidemiology, 159 (2), 113–123.
   PubMed Web of Science ®Google Scholar
• Wise, L.A., et al., 2004b. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women’s Health Study. Human Reproduction , 19 (8), 1746–1754.
   PubMed Web of Science ®Google Scholar
• Wise, L.A., et al., 2005. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology, 16 (3), 346–354.
   PubMed Web of Science ®Google Scholar
• Wise, L.A., et al., 2011. Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata. The American Journal of Clinical Nutrition, 94 (6), 1620–1631.
   PubMed Web of Science ®Google Scholar
• Wise, L.A., et al., 2010. A prospective study of dairy intake and risk of uterine leiomyomata. American Journal of Epidemiology, 171 (2), 221–232.
   PubMed Web of Science ®Google Scholar
• Wise, L.A., et al., 2021. Intake of lycopene and other carotenoids and incidence of uterine leiomyomata: A prospective ultrasound study. Journal of the Academy of Nutrition and Dietetics, 121 (1), 92–104.
   PubMed Web of Science ®Google Scholar
• Xie, Z.W., et al., 2012. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma. The Journal of International Medical Research, 40 (5), 1966–1972.
   PubMed Web of Science ®Google Scholar
• Yang, Y., et al., 2014. Association of body size and body fat distribution with uterine fibroids among Chinese women. Journal of Women’s Health (2002), 23 (7), 619–626.
   PubMed Web of Science ®Google Scholar
• Zadshir, A., et al., 2005. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethnicity and Disease, 15 (4 Suppl 5), S5–S101.
   Web of Science ®Google Scholar